Interaction of Vascular Endothelial Growth Factor 165 with Neuropilin-1 Protects Rheumatoid Synoviocytes from Apoptotic Death by Regulating Bcl-2 Expression and Bax Translocation

作者: Wan-Uk Kim , Soon Suk Kang , Seung-Ah Yoo , Kyung-Hee Hong , Dong-Goo Bae

DOI: 10.4049/JIMMUNOL.177.8.5727

关键词:

摘要: Rheumatoid arthritis (RA) synoviocytes are resistant to apoptosis and exhibit a transformed phenotype, which might be caused by chronic exposure genotoxic stimuli including reactive oxygen species growth factors. In this study, we investigated the role of vascular endothelial factor165 (VEGF165), potent angiogenic factor, its receptor in synoviocytes. We demonstrated here that neuropilin-1, rather than fms-like tyrosine kinase-1 kinase insert domain-containing receptor, is major VEGF165 fibroblast-like Neuropilin-1 was highly expressed lining layer, infiltrating leukocytes, cells rheumatoid synovium. The production VEGF165, ligand for neuropilin, significantly higher RA osteoarthritis ligation recombinant prevented induced serum starvation or sodium nitroprusside (SNP). rapidly triggered phospho-Akt phospho-ERK activity then Bcl-2 expression Akt ERK inhibitor cancelled protective effect on SNP-induced synoviocyte apoptosis. Moreover, blocks down-regulation as well Bax translocation from cytosol mitochondria. neuropilin-1 transcripts short interfering RNA spontaneous apoptosis, associated with both decrease increase Collectively, our data suggest interaction crucial survival provide important implications abnormal therapeutic intervention RA.

参考文章(45)
M. L. Ho, J. R. Jackson, N. Wei, J. D. Winkler, J. A. L. Minton, Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. The Journal of Rheumatology. ,vol. 24, pp. 1253- 1259 ,(1997)
Min Jk, Min Dj, Kim Wu, Cho Cs, Kim Hy, Park Sh, Lee Ss, Joo Ys, Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clinical and Experimental Rheumatology. ,vol. 19, pp. 321- 324 ,(2001)
Felix Mor, Francisco J. Quintana, Irun R. Cohen, Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. Journal of Immunology. ,vol. 172, pp. 4618- 4623 ,(2004) , 10.4049/JIMMUNOL.172.7.4618
Seung-Ah Yoo, Dong-Goo Bae, Jae-Woong Ryoo, Hae-Rim Kim, Gyeong-Sin Park, Chul-Soo Cho, Chi-Bom Chae, Wan-Uk Kim, Arginine-Rich Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Hexapeptide Inhibits Collagen-Induced Arthritis and VEGF-Stimulated Productions of TNF-α and IL-6 by Human Monocytes Journal of Immunology. ,vol. 174, pp. 5846- 5855 ,(2005) , 10.4049/JIMMUNOL.174.9.5846
Harris Perlman, Constantinos Georganas, Lisa J. Pagliari, Alisa E. Koch, Kenneth Haines, Richard M. Pope, Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. Journal of Immunology. ,vol. 164, pp. 5227- 5235 ,(2000) , 10.4049/JIMMUNOL.164.10.5227
Arthur M. Mercurio, Robin E. Bachelder, Melissa A. Wendt, Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Research. ,vol. 62, pp. 7203- 7206 ,(2002)
Tae-Hee Lee, Hava Avraham, Seung-Hoon Lee, Shalom Avraham, Vascular Endothelial Growth Factor Modulates Neutrophil Transendothelial Migration via Up-regulation of Interleukin-8 in Human Brain Microvascular Endothelial Cells Journal of Biological Chemistry. ,vol. 277, pp. 10445- 10451 ,(2002) , 10.1074/JBC.M107348200
G. S. Firestein, F. Echeverri, M. Yeo, N. J. Zvaifler, D. R. Green, Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 10895- 10900 ,(1997) , 10.1073/PNAS.94.20.10895
Arthur M Mercurio, Robin E Bachelder, Richard C Bates, Jun Chung, Autocrine signaling in carcinoma: VEGF and the α6β4 integrin Seminars in Cancer Biology. ,vol. 14, pp. 115- 122 ,(2004) , 10.1016/J.SEMCANCER.2003.09.016